Trials / Recruiting
RecruitingNCT06800768
The Value of 68Ga-FAPI PET/CT in Detecting Recurrent and Metastatic Lesions in Patients with Thyroid Cancer After Surgery
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (estimated)
- Sponsor
- Ruijin Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to investigate the value of 68Ga-FAPI PET/CT in detecting recurrent and metastatic lesions in patients with thyroid cancer after surgery.
Detailed description
The investigators will number all participants, create a medical record file, and record their basic information (gender, age) as well as contact information and medical history information. All participants will undergo a 68Ga-FAPI PET/CT when recurrence or metastasis is suspected. The imaging response measurements will be compared with follow-up results or histopathological findings as the gold standard.
Conditions
Timeline
- Start date
- 2025-02-01
- Primary completion
- 2030-01-31
- Completion
- 2030-01-31
- First posted
- 2025-01-30
- Last updated
- 2025-01-30
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06800768. Inclusion in this directory is not an endorsement.